Development of Thyroid Hormones and Synthetic Thyromimetics in Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is the fastest-growing liver disease in the world. Despite targeted agents which are needed to provide permanent benefits for patients with NAFLD, no drugs have been approved to treat NASH. Thyroid hormone is an important signaling molecule to maintain norma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Man, Xie, Huazhong, Shan, Hao, Zheng, Zhihua, Li, Guofeng, Li, Min, Hong, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835192/
https://www.ncbi.nlm.nih.gov/pubmed/35163026
http://dx.doi.org/10.3390/ijms23031102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835192/
https://www.ncbi.nlm.nih.gov/pubmed/35163026
http://dx.doi.org/10.3390/ijms23031102

Ejemplares similares